| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $2.19B | $2.05B | $1.64B | $795.69M | $584.87M | $352.55M |
| Cost of Revenue | $79.63M | $31.28M | $17.54M | $0.00 | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | $77.43M |
| R&D | – | – | – | – | – | – |
| SG&A | $222.34M | $162.47M | $120.89M | $59.97M | $23.53M | $11.12M |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | $501.11M | $208.95M | $65.45M | $27.37M |
| Tax Expense | $72.64M | $28.43M | $60.42M | $42.78M | $38.53M | -$30.10M |
| Net Income | $153.33M | $84.65M | $375.54M | $205.14M | $217.94M | $142.92M |
| EPS (basic) | 2.5600 | 1.4300 | 6.3700 | 3.5000 | 3.6700 | 2.4500 |
| EPS (diluted) | 2.5100 | 1.4000 | 6.3300 | 3.4500 | 3.6700 | 2.4500 |
| Shares (diluted) | $61.12M | $60.49M | $59.36B | $59.50B | $59.38M | $58.44B |